Craft

MEDICAMEN Biotech

Stock Price

₹486.8

2024-10-29

Market Capitalization

₹7.1 B

2024-10-29

Revenue

₹1.6 B

FY, 2025

MEDICAMEN Biotech Summary

Company Summary

Overview
MEDICAMEN Biotech (MBL) is a provider of therapeutic solutions for well-being and life. It offers vitamins, supplements, and other generics. The company specializes in the therapeutic areas of cardiology. diabetology, cancer care, pain management, etc.
Type
Public
Status
Active
Founded
1993
Website
https://medicamen.com
Cybersecurity rating
Sectors

Key People

  • Rahul Bishnoi
  • Rajesh Madan

    Rajesh Madan, Chief Executive Officer

    • Vimal Shrawat

      Vimal Shrawat, Director

      • Ashwani Kumar Sharma

      MEDICAMEN Biotech Financials

      Summary Financials

      Revenue (Q3, 2026)
      ₹469.1M
      Gross profit (Q3, 2026)
      ₹237.3M
      Net income (Q3, 2026)
      ₹16.3M
      Cash (Q2, 2026)
      ₹436.8M
      EBIT (Q3, 2026)
      ₹30.8M
      Enterprise value
      $7.1B

      Footer menu